Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and ...

The registration window for the SRMJEE Phase 1 2025 application ends today, April 16, 2025. Aspirants who are eligible and ...

MetaVia (MTVA) announced positive results from the 4-week multiple ascending dose Part 2 of its Phase 1 clinical trial of DA-1726, a novel, ...

Eyestem Research Pvt Ltd announced positive results from its phase 1/2 trial ( NCT06394232) evaluating its investigational ...

Jonathan Kimmelman, PhD, has published multiple research papers and gotten into an inordinate number of debates about the clinical value of phase 1 trials.“I’ve argued for a long time that for phase 1 ...

Perspective, Therapeutics announced that the first patient was dosed in a new cohort of a Phase 1/2a trial evaluating the safety of 212PbVMT01, ...

The new units will be part of Phase 2 of the development and will include amenities such as a dog park and community pool.

Recursion Pharmaceuticals, a trailblazing TechBio company, has made a significant stride in the realm of oncology by dosing the first patient in its Phase 1 clinical trial for a potential B-cell ...

Elevation Oncology is ditching its sole clinical-stage asset in the wake of disappointing phase 1 data, leading the antibody-drug conjugate company to lay off 70% of its staff. The biotech had ...